in Nucleic Acid Therapeutics for Human Health


  • HOME
  • PR
  • News
Subject Updated Data of OLX301A
Writer 관리자 Date 2019.05.23 See 870
files file

OliX Pharmaceuticals (KOSDAQ: 226950) gives the Poster Presentation with Updated Data from ongoing Wet & Dry AMD Preclinical studies of OLX301A in the CNV model of Rhesus Monkeys at #TIDES in San Diego on May 23.